A drug used to treat advanced breast and colorectal cancers has been linked to sometimes fatal skin reactions in patients, its Swiss manufacturer and Canadian health officials said Wednesday.
Xeloda, which treats advanced cancer after complete surgical removal, can cause "severe skin reactions," Health Canada said in a statement.
It said patients had reported severe skin reactions, such as the life-threatening skin condition known as Stevens-Johnson Syndrome or toxic epidermal necrolysis.
The signs and symptoms of this hypersensitivity include flu-like symptoms, fever, itchy skin, mouth sores, as well as painful, red or purplish skin rash that spreads and blisters, causing the top of the skin to shed, along with eye burning, itching and discharge.
Health Canada urged patients using Xeloda to contact their physician "immediately" after experiencing any of those signs or symptoms, so that they may report these adverse reactions to Roche or Health Canada.
Following requests from Canadian health authorities, Hoffmann-La Roche said it will be working with Health Canada to update the drug's prescribing information document.
It has sent a letter to healthcare professionals warning of the "risk of severe cutaneous reactions associated with the use of Xeloda," though it stressed that those cases were "very rare."
Explore further: FDA warns of rare skin reactions to acetaminophen
© 2013 AFP
Medical Xpress on facebook
Related Stories
FDA warns of rare skin reactions to acetaminophen
Aug 02, 2013
(HealthDay)—The widely used painkiller acetaminophen, best known as Tylenol, can cause rare but serious skin reactions and a warning about this danger will be added to product labels, the U.S. Food and ...
Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds
Nov 01, 2012
(Medical Xpress)—Skin reactions following radiation therapy for breast cancer have been the focus of a recent clinical trial conducted by Dr Patries Herst from the Department of Radiation Therapy, University ...
Temporary tattoos may leave permanent damage
Mar 26, 2013
(HealthDay)—As thousands of college students head to sunny spots for spring break, getting temporary tattoos may seem like a fun thing to do. But the U.S. Food and Drug Administration warns that they can ...
At least 23 Canadian deaths linked to contraceptive
Jun 11, 2013
At least 23 Canadian women died and hundreds more may have been harmed taking the world's two most commonly prescribed birth control pills, the country's public broadcaster said Tuesday.
EU regulator: No more problems with Roche drugs
Nov 19, 2013
The European Medicines Agency says it has finished an investigation of the way pharmaceutical giant Roche reported side effects for 19 drugs in the U.S. and has found no new safety concerns.
Recommended for you
Large differences in cancer survival between European countries still remain despite major improvements in cancer diagno
10 hours ago
Cancer survival still varies widely between European countries despite major improvements in cancer diagnosis and treatment during the first decade of the 21st century, according to the latest EUROCARE-5 reports covering ...
Researchers unravel important role of Rb tumor suppressor in aggressive form of breast cancer
11 hours ago
The retinoblastoma (Rb) protein plays a critical role in suppressing the multi-step process of cell migration through the bloodstream, lymphovascular invasion and the metastasis of an aggressive type of breast cancer to the ...
Shape-shifting stops migrating cancer cells
11 hours ago
Like a car with a front and back end, a steering mechanism and an engine to push it forward, cancer cells propel themselves through normal tissues and organs to spread cancer throughout the body. Researchers at Mayo Clinic ...
Active component of grape seed extract effective against cancer cells
12 hours ago
A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, ...
Predicting ovarian cancer survival through tumor-attacking immune cells
14 hours ago
One way to predict survival of many types of cancer is by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate it – a sign of the body's immune response to the ...
Low rate of malignancy for BI-RADS category 3 lesions
14 hours ago
(HealthDay)—A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ultrasonography (US), according to research published ...
User comments
© Medical Xpress 2011-2013, Phys.org network
A drug used to treat advanced breast and colorectal cancers has been linked to sometimes fatal skin reactions in patients, its Swiss manufacturer and Canadian health officials said Wednesday.
Xeloda, which treats advanced cancer after complete surgical removal, can cause "severe skin reactions," Health Canada said in a statement.
It said patients had reported severe skin reactions, such as the life-threatening skin condition known as Stevens-Johnson Syndrome or toxic epidermal necrolysis.
The signs and symptoms of this hypersensitivity include flu-like symptoms, fever, itchy skin, mouth sores, as well as painful, red or purplish skin rash that spreads and blisters, causing the top of the skin to shed, along with eye burning, itching and discharge.
Health Canada urged patients using Xeloda to contact their physician "immediately" after experiencing any of those signs or symptoms, so that they may report these adverse reactions to Roche or Health Canada.
Following requests from Canadian health authorities, Hoffmann-La Roche said it will be working with Health Canada to update the drug's prescribing information document.
It has sent a letter to healthcare professionals warning of the "risk of severe cutaneous reactions associated with the use of Xeloda," though it stressed that those cases were "very rare."
Explore further: FDA warns of rare skin reactions to acetaminophen
© 2013 AFP
Medical Xpress on facebook
Related Stories
FDA warns of rare skin reactions to acetaminophen
Aug 02, 2013
(HealthDay)—The widely used painkiller acetaminophen, best known as Tylenol, can cause rare but serious skin reactions and a warning about this danger will be added to product labels, the U.S. Food and ...
Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds
Nov 01, 2012
(Medical Xpress)—Skin reactions following radiation therapy for breast cancer have been the focus of a recent clinical trial conducted by Dr Patries Herst from the Department of Radiation Therapy, University ...
Temporary tattoos may leave permanent damage
Mar 26, 2013
(HealthDay)—As thousands of college students head to sunny spots for spring break, getting temporary tattoos may seem like a fun thing to do. But the U.S. Food and Drug Administration warns that they can ...
At least 23 Canadian deaths linked to contraceptive
Jun 11, 2013
At least 23 Canadian women died and hundreds more may have been harmed taking the world's two most commonly prescribed birth control pills, the country's public broadcaster said Tuesday.
EU regulator: No more problems with Roche drugs
Nov 19, 2013
The European Medicines Agency says it has finished an investigation of the way pharmaceutical giant Roche reported side effects for 19 drugs in the U.S. and has found no new safety concerns.
Recommended for you
Large differences in cancer survival between European countries still remain despite major improvements in cancer diagno
10 hours ago
Cancer survival still varies widely between European countries despite major improvements in cancer diagnosis and treatment during the first decade of the 21st century, according to the latest EUROCARE-5 reports covering ...
Researchers unravel important role of Rb tumor suppressor in aggressive form of breast cancer
11 hours ago
The retinoblastoma (Rb) protein plays a critical role in suppressing the multi-step process of cell migration through the bloodstream, lymphovascular invasion and the metastasis of an aggressive type of breast cancer to the ...
Shape-shifting stops migrating cancer cells
11 hours ago
Like a car with a front and back end, a steering mechanism and an engine to push it forward, cancer cells propel themselves through normal tissues and organs to spread cancer throughout the body. Researchers at Mayo Clinic ...
Active component of grape seed extract effective against cancer cells
12 hours ago
A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, ...
Predicting ovarian cancer survival through tumor-attacking immune cells
14 hours ago
One way to predict survival of many types of cancer is by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate it – a sign of the body's immune response to the ...
Low rate of malignancy for BI-RADS category 3 lesions
14 hours ago
(HealthDay)—A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ultrasonography (US), according to research published ...
User comments
© Medical Xpress 2011-2013, Phys.org network
No comments:
Post a Comment